Physician

Internal Medicine

Dr. Andrea B. Apolo, MD

Andrea Apolo practices Internal Medicine. She went to Albert Einstein College of Medicine of Yeshiva University. Dr. Andrea B. Apolo is also published. She has 22 publications published. The lastest publication: "Emerging immunotherapies for bladder cancer.'

Publications

Emerging immunotherapies for bladder cancer.
Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward.
New facial papules in a 66-year-old woman with bladder cancer.
Cutaneous Adverse Effects Associated With the Tyrosine-Kinase Inhibitor Cabozantinib.
The 19q12 Bladder Cancer GWAS Signal: Association with Cyclin E Function and Aggressive Disease.
Phase Ib/II Trial of Gemcitabine, Cisplatin, and Lenalidomide as First-Line Therapy in Patients With Metastatic Urothelial Carcinoma.
Rapid development of migratory, linear, and serpiginous lesions in association with immunosuppression.
Targeted therapies in urothelial carcinoma.
Cabozantinib-Induced Thyroid Dysfunction: A Review of Two Ongoing Trials for Metastatic Bladder Cancer and Sarcoma.
Consistency and Efficiency of CT Analysis of Metastatic Disease: Semiautomated Lesion Management Application Within a PACS.
Phase II Study of Gemcitabine, Carboplatin, and Bevacizumab in Patients With Advanced Unresectable or Metastatic Urothelial Cancer.
Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy.
Genetic variant as a selection marker for anti-prostate stem cell antigen immunotherapy of bladder cancer.
Practical use of perioperative chemotherapy for muscle-invasive bladder cancer: Summary of session at the Society of Urologic Oncology annual meeting.
Tumor-Intrinsic and Tumor-Extrinsic Factors Impacting Hsp90-Targeted Therapy.
The Kinetics and Reproducibility of 18F-Sodium Fluoride for Oncology Using Current PET Camera Technology.
Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in bladder cancer.
Novel tracers and their development for the imaging of metastatic prostate cancer.
Clinical states model for biomarkers in bladder cancer.
Neoadjuvant chemotherapy use in bladder cancer: a survey of current practice and opinions.
Characterization of HGF/Met Signaling in Cell Lines Derived From Urothelial Carcinoma of the Bladder.

Doctors Specialties

Medical Oncology
Oncology
Internal Medicine

Accepted Insurances

Education

Memorial Sloan-Kettering Cancer Center
New York Presbyterian Hospital
Albert Einstein College of Medicine of Yeshiva University

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Michael J. Hamilton, MD
	Dr. Geraldine H. O'Sullivan, MD
	Dr. Syed A. Ali, MD
	Dr. Edwin P. Rock, MD
	Dr. Victor M. Priego, MD This Doctor is OpenDoctor Recommended.
	Dr. Suparna B. Wedam, MD This Doctor is OpenDoctor Recommended.
	Dr. Ravi A. Madan, MD
	Dr. Georg Aue, MD This Doctor is OpenDoctor Recommended.
	Dr. Gary M. Roggin, MD This Doctor is OpenDoctor Recommended.
	Dr. Sam O. Wanko, MD
	Barbara Martinez This Doctor is OpenDoctor Recommended.
	Dr. Enkhtsetseg Purev, MD
	Dr. Kevan M. Akrami, MD This Doctor is OpenDoctor Recommended.
	Dr. Allison W. Venner, MD This Doctor is OpenDoctor Recommended.
	Dr. Jurrien Dean, MD
	Dr. Donna L. Rinis, MD This Doctor is OpenDoctor Recommended.